Enzyme linked immunosorbent assay (ELISA) plays an important role in laboratory confirmation 31 of congenital rubella syndrome (CRS), postnatal rubella and seroprevalence studies in different 32 
Introduction 52
Rubella is an acute, contagious vaccine preventable viral infection, which usually causes a mild 53 exanthematous febrile illness in children or young adults. Infection with rubella virus during 54 pregnancy, particularly in the first trimester, can cause congenital rubella syndrome (CRS), 55 detection of rubella specific IgM and IgG antibodies, among suspected cases of CRS and 79 pregnant women respectively. 80
Materials and Methods 82
Ethics statement: The study was approved by the Institutional Ethics committees of all sentinel 83 sites. Participants were enrolled in the study after obtaining written informed consent from 84 pregnant women and parents / guardians of infants. 85
Study population and sample selection: Suspected CRS cases were identified among infants 86 (0-11 months) attending pediatrics, ear nose and throat (ENT), ophthalmology, and cardiology 87
Outpatient Departments (OPDs) of six sentinel hospitals. These are tertiary care centers 88 providing medical care to local children as well as those from surrounding states. Pregnant 89 women attending antenatal clinics at these hospitals during March/April -May/June 2017 were 90 eligible to participate in the serosurvey. 91
Study samples and case definition: Suspected cases were recruited as per WHO-92 recommended standards for CRS surveillance (5). Serum samples (n=291) were collected, 93 aliquoted and stored (testing aliquot at 2-8 degree C and remaining aliquots at -20°C) until 94 transported in cold chain to the apex laboratory (ICMR-National Institute of Virology, Pune). 95
Procurement of kits was centralized and all the sentinel sites were provided kits transported in 96 cold chain. 97
Testing of samples: Testing was performed using commercial ELISA kit for detection of anti 98 rubella IgM and IgG antibodies (Euroimmun, Luebeck, Germany). All the samples from 99 suspected CRS cases were tested for rubella specific IgM antibodies at the sentinel sites. 100
Serum samples collected from 1800 pregnant women in a serosurvey between March/AprilAt ICMR-NIV, Pune, 285 of 291 serum samples collected from suspected CRS patients and 435 103 of 1800 samples from pregnant women were available for testing. These samples were tested 104 by Euroimmun ELISA for the purpose of quality control. To determine agreement between the 105 two kits for detection of anti rubella IgM and IgG antibodies, these samples were retested by 106 Enzygnost Rubella ELISA. Anti rubella IgG titres were extrapolated from a four-point standard 107 curve comprising of calibrators with different concentrations of antibodies, as per manufacturer's 108 instructions. Titers above the upper limit of detection of 200 IU/ml were denoted as 201 IU/ml 109 and values below lower limit of detection(1IU/ml), were taken as 0.5 IU/ml (Euroimmun). Titres 110 for IgG obtained with the Enzygnost kit, were calculated using the α and β constants whose 111 values are provided with the kit. 112
Samples, whose results were discordant between the two kits, were retested in duplicate and 2 113 of 3 results were considered final. All equivocal samples were also re tested in duplicate and 114 any samples which still remained equivocal were excluded from analysis. Chemiluminiscence 115 assay (CLIA) was performed at two of the network laboratories for samples which remained 116 discordant after testing in triplicate. The VITROS 3600 Immunodiagnostic system (Orthoclinical 117 Diagnostics, Raritan, NJ) and the Liaison (DiaSorin, Saluggia, Italy) systems were used for 118 testing IgM and IgG respectively. A sample was considered a true positive or a true negative if 119 concordance of at least two of the three methods was obtained. 120
Measurement of intra assay and inter assay precision:
The intra assay precision was 121 calculated by testing duplicates of samples within a single run, by the two ELISA systems for 122 both rubella specific IgM and IgG. For determination of inter assay precision, positive controls of 123 same lot provided by the manufacturer, were run repeatedly on different days. The coefficient of 124 variation (CV) was calculated. 125
The mean absorbance of positive control wells was compared between the two kits for rubella 126 specific IgM and IgG. The characteristics of the kits used in the study are provided Through the present study, a uniform strategy of laboratory testing for CRS and population 184 survey of pregnant women was established for the first time in India. The study reports the 185 critical evaluation of the comparability between Euroimmun and Enzygnost ELISA kits for 186 rubella specific IgM in suspected cases of congenital rubella syndrome and rubella specific IgG 187 in serosurvey of pregnant women. Previous reports from India on CRS in different "at risk 188 groups" (7), have used different testing strategies for laboratory confirmation of CRS. 189
Evaluation of the performance of Euroimmun and Enzygnost kits for detection of Rubella
Our results demonstrate satisfactory performance of both kits. Good individual reproducibility 190 was observed, as evidenced by intra assay precision, with slightly higher CV for inter assay 191 precision (Table 3&4) 
